EGFR Mutational Status and PD-L1 in Early-Stage Brazilian Non-Small-Cell Lung Cancer

被引：0
|
作者：
De Oliveira Cavagna, R. [1 ]
Alves Pinto, I. [1 ]
Virginio Da Silva, A. L. [1 ]
Santana, I. [2 ]
Mourao Dias, J. [3 ]
Souza, L. C. [3 ]
Ferreira Da Silva, F. A. [3 ]
Biazotto Fernandes, M. F. [3 ]
Dix Junqueira Pinto, G. [3 ]
Santos Negreiros, I. [3 ]
Escremim De Paula, F. [4 ]
Noriz Berardinelli, G. [4 ]
Stanfoca Casagrande, G. M. [1 ]
Santiago Goncalves, M. F. [1 ]
Albino Da Silva, E. C. [2 ]
Duval Da Silva, V. [2 ]
De Marchi, P. [5 ]
Vieira Reis, R. M. [1 ]
Ferro Leal, L. [6 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol, Barretos, Brazil
[2] Barretos Canc Hosp, Dept Pathol, Barretos, Brazil
[3] Barretos Canc Hosp, Dept Med Oncol, Barretos, Brazil
[4] Barretos Canc Hosp, Dept Mol Diag, Barretos, Brazil
[5] Oncoclinicas, Rio De Janeiro, Brazil
[6] Barretos Sch Hlth Sci Dr Paulo Prata Facisb, Barretos, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
PD-L1; EGFR; adjuvant therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P57.06
引用
收藏
页码：S1139 / S1139
页数：1
相关论文
共 50 条
  • [1] Targeting PD-L1 for non-small-cell lung cancer
    Feld, Emily
    Horn, Leora
    IMMUNOTHERAPY, 2016, 8 (06) : 747 - 758
  • [2] PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation
    Mei Ji
    Yan Liu
    Qing Li
    Xiao-Dong Li
    Wei-Qing Zhao
    Hanze Zhang
    Xiaofei Zhang
    Jing-Ting Jiang
    Chang-Ping Wu
    Journal of Translational Medicine, 13
  • [3] PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation
    Ji, Mei
    Liu, Yan
    Li, Qing
    Li, Xiao-Dong
    Zhao, Wei-Qing
    Zhang, Hanze
    Zhang, Xiaofei
    Jiang, Jing-Ting
    Wu, Chang-Ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [4] PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis
    Li, Jing
    Gu, Jian
    FUTURE ONCOLOGY, 2019, 15 (14) : 1667 - 1678
  • [5] Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
    Shen, Xuxia
    Li, Yuan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1817 - 1818
  • [6] The Value of PD-L1 Testing in Non-Small-Cell Lung Cancer
    Lisberg, Aaron
    Garon, Edward B.
    JAMA ONCOLOGY, 2016, 2 (05) : 571 - 572
  • [7] Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
    Shen, Xuxia
    Li, Yuan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1817 - 1818
  • [8] Surgery for early-stage non-small-cell lung cancer
    Mordant, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (02): : 266 - 274
  • [9] PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutations
    Ji, Mei
    Liu, Yan
    Li, Qing
    Li, Xiaodong
    Ning, Zhonghua
    Zhao, Weiqing
    Shi, Hongbing
    Jiang, Jingting
    Wu, Changping
    CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 407 - 413
  • [10] Tumor Mutational Burden and PD-L1 Expression in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Ye, Lianhua
    Li, Hongsheng
    Wang, Xiaoxiong
    Liu, Junxi
    Shen, Zhenghai
    Ma, Luyao
    Zhou, Yongchun
    ONCOTARGETS AND THERAPY, 2020, 13 : 5191 - 5198
12345